CDEK
← All organizations

CymaBay Therapeutics, Inc.

For profitWebsite ↗

Also known as: CymaBay Therapeutics, Inc. | Metabolex, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

May 1, 2006

Last known activity

Sep 7, 2023

Acquired by Gilead Sciences on Feb 12, 2024

Timeline

1980s

  1. Jun 1, 1988

    CymaBay Therapeutics, Inc.— Founded

2020s

  1. Feb 12, 2024

    Gilead Sciences— Acquired By

Drugs by trial phase (11 distinct, 23 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (30)

Details

Founded
Newark, CA, US Jun 1, 1988
Last known activity
Sep 7, 2023